Evaxion A (EVAX) Capital Expenditures (2020 - 2022)
Evaxion A posted quarterly Capital Expenditures of -$83000.0 for Q2 2022, up 89.52% year-on-year from -$43794.8 in Q2 2021, and up 54.14% on a QoQ basis from -$181000.0 in Q1 2022.
Evaxion A (EVAX) has 3 years of Capital Expenditures data on file, last reported at -$83000.0 in Q2 2022.
- For the quarter ending Q2 2022, Capital Expenditures rose 89.52% year-over-year to -$83000.0; the trailing twelve-month figure through Jun 2022 stood at -$2.2 million (down 78.1% YoY), and the FY2025 full-year result was $11000.0, changed N/A from the prior year.
- Capital Expenditures for Q2 2022 stood at -$83000.0, up from -$181000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at -$64000.0 in Q1 2020 and bottomed at -$1.1 million in Q3 2021.
- The 3-year median for Capital Expenditures is -$132000.0 (2022), against an average of -$334500.0.
- The widest annual swing landed in 2021, when Capital Expenditures slumped 1378.95%; it then jumped 89.52% in 2022.
- A 3-year view of Capital Expenditures shows it stood at -$76000.0 in 2020, then plunged by 1378.95% to -$1.1 million in 2021, then jumped by 92.62% to -$83000.0 in 2022.
- The last three Capital Expenditures figures came in at -$83000.0 (Q2 2022), -$181000.0 (Q1 2022), and -$1.1 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 786,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -83,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Sep 30, 2021 | -1.12 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -792,000.00 |
| Jun 30, 2021 | -792,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Mar 31, 2020 | -64,000.00 |
| Mar 31, 2020 | -64,000.00 |